In Brief: Ciba Self-Medication

Ciba Self-Medication: Lisa Gonzalez named VP-marketing for Ciba Self-Medication and of Novartis Self-Medication pending regulatory approval of the Ciba/Sandoz merger, effective Sept. 23. Gonzalez currently is VP-Americas of Glaxo Wellcome's OTC Commercial Operations unit, with commercial oversight for all North American switches. Charlie Lay assumes management responsibility for Ciba's U.S. Pharmaceuticals Division following the departure of James Callahan, who had been tapped as Novartis U.S. CEO but opted to take early retirement "for personal and professional reasons," Ciba says. Sandoz Corp. CEO E.J. Fullagar has been given responsibility for the integration of the Ciba/Sandoz U.S. pharmaceutical business until a new CEO is found. The search firm Russell Reynolds has been hired to help find a replacement...